A Clinical Study on Efficacy And Safety of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression A Multicenter, Randomized, Double-Blind, Parallel Controlled Study

Trial Profile

A Clinical Study on Efficacy And Safety of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression A Multicenter, Randomized, Double-Blind, Parallel Controlled Study

Completed
Phase of Trial: Phase II/III

Latest Information Update: 22 Oct 2014

At a glance

  • Drugs Trazodone (Primary)
  • Indications Major depressive disorder
  • Focus Registrational; Therapeutic Use
  • Sponsors Lees Pharmaceutical Holdings
  • Most Recent Events

    • 02 Oct 2013 Status changed from active, no longer recruiting to completed according to a Lee's Pharmaceutical Holdings media release.
    • 02 Oct 2013 Primary endpoint 'Change in Hamilton Depression Rating Scale-17 score' has been met, according to a Lee's Pharmaceutical Holdings media release.
    • 01 Oct 2013 Primary endpoint results have been published in a Pharmaceutical Holdings media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top